Mahazarin Behram Ginwalla, MD
Advanced Heart Failure and Transplant Cardiology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 7
- Since medical school
- 24 years
- Graduated 2002
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ginwalla’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A114478 · Current
Licensed to practise in California · since 2019 · expires 2027-09-30 · University of Mumbai, Lokmanya Tilak Municipal Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Advanced Heart Failure and Transplant
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$261,738
Medicare paid this office $261,738 for 543 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 117 | $65,790 | $183 |
| Long return visit (40+ min) | 149 | $46,616 | $162 |
| Return visit (30+ min) | 219 | $39,593 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $34,347 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $29,479 | $190 |
See all 17 services
| Critical care, first 30-74 minutes | 117 | $65,790 | $183 |
| Long return visit (40+ min) | 149 | $46,616 | $162 |
| Return visit (30+ min) | 219 | $39,593 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $34,347 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $29,479 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 108 | $18,464 | $145 |
| New patient visit (60+ min) | 37 | $7,422 | $201 |
| Ultrasound of heart, follow-up | 25 | $4,019 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,823 | $57 |
| External shock to heart to regulate heart beat | 22 | $2,228 | $97 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,869 | $93 |
| Heart muscle strain imaging | 45 | $1,774 | $39 |
| 3d radiographic procedure | 37 | $955 | $25 |
| Ultrasound of heart, follow-up | 22 | $529 | $22 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 24 | $357 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $299 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $85 | $3 |
Who their Medicare patients are
543 Original Medicare patients in 2024. Average age 79 · Under 65 4% · 85 and older 31% · Women 47% · Also on Medicaid 17% · Health risk score 2.39. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 2.53.
Conditions among them: High blood pressure 75% · Heart failure 75% · Coronary heart disease 62% · Atrial fibrillation 61% · Chronic kidney disease 55% · Diabetes 45% · COPD 26% · Depression 25% · Cancer 22% · Dementia 18% · Stroke 15%.
The office billed $1,135,979, Medicare allowed $341,334 and paid $261,738; for 2,063 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 543 | 2,063 | 79 | 2.39 | $1,135,979 | $261,738 |
| 2023 | 493 | 1,811 | 78 | 2.30 | $996,797 | $240,024 |
| 2022 | 438 | 1,838 | 78 | 2.14 | $844,112 | $217,874 |
| 2021 | 371 | 1,578 | 78 | 2.34 | $740,726 | $198,447 |
| 2020 | 285 | 981 | 78 | 1.96 | $373,015 | $112,239 |
| 2019 | 272 | 851 | 70 | 3.03 | $248,146 | $69,975 |
| 2018 | 409 | 1,191 | 71 | 2.93 | $329,257 | $90,383 |
| 2017 | 421 | 1,198 | 70 | 2.91 | $331,438 | $92,759 |
| 2016 | 403 | 1,391 | 70 | 3.00 | $393,299 | $107,118 |
| 2015 | 376 | 1,231 | 69 | 3.02 | $355,147 | $100,299 |
| 2014 | 428 | 1,496 | 68 | 2.80 | $448,663 | $121,686 |
| 2013 | 239 | 670 | 67 | 2.60 | $151,521 | $49,242 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Critical care, first 30-74 minutes | 116 | $69,832 | $188 |
| Long return visit (40+ min) | 150 | $44,606 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $28,994 | $107 |
| Return visit (30+ min) | 159 | $23,538 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 98 | $20,967 | $194 |
| New patient visit (60+ min) | 63 | $12,739 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $12,445 | $154 |
| Ultrasound of heart, follow-up | 22 | $2,389 | $100 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,926 | $96 |
| External shock to heart to regulate heart beat | 18 | $1,783 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 28 | $1,750 | $62 |
| Heart muscle strain imaging | 22 | $898 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 58 | $775 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $399 | $25 |
| 3d radiographic procedure | 15 | $372 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $358 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $259 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $76 | $3 |
2022: 20 services
| Long return visit (40+ min) | 145 | $57,281 | $164 |
| Critical care, first 30-74 minutes | 75 | $35,777 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $33,201 | $90 |
| Return visit (30+ min) | 140 | $22,160 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $18,089 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $17,675 | $194 |
| New patient visit (60+ min) | 46 | $9,114 | $198 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $3,221 | $95 |
| Ultrasound of heart, follow-up | 20 | $2,678 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $1,909 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | $1,888 | $14 |
| External shock to heart to regulate heart beat | 15 | $1,588 | $99 |
| Short return visit (20+ min) | 12 | $1,043 | $87 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $721 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $693 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $325 | $15 |
| 3d radiographic procedure | 11 | $256 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $153 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $118 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $68 | $3 |
2021: 18 services
| Critical care, first 30-74 minutes | 78 | $47,761 | $194 |
| Long return visit (40+ min) | 99 | $43,044 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 141 | $37,345 | $93 |
| Return visit (30+ min) | 95 | $19,277 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $17,626 | $180 |
| New patient visit (60+ min) | 23 | $4,713 | $205 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $4,243 | $212 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $3,371 | $99 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,279 | $81 |
| Critical care, each additional 30 minutes | 14 | $1,852 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,598 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,319 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $1,165 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 53 | $771 | $13 |
| Short return visit (20+ min) | 11 | $601 | $55 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $365 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $169 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $75 | $3 |
2020: 15 services
| Critical care, first 30-74 minutes | 61 | $21,996 | $200 |
| Return visit (30+ min) | 76 | $20,672 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $15,241 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $10,304 | $187 |
| Long return visit (40+ min) | 41 | $7,620 | $139 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $6,346 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $5,146 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,253 | $125 |
| New patient visit (60+ min) | 20 | $4,071 | $204 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $2,758 | $212 |
| New patient visit (45+ min) | 15 | $2,456 | $164 |
| Short return visit (20+ min) | 26 | $1,999 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $1,975 | $66 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,161 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $432 | $16 |
2019: 18 services
| Critical care, first 30-74 minutes | 38 | $26,150 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $8,059 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $5,283 | $57 |
| Return visit (30+ min) | 45 | $5,150 | $61 |
| Evaluation of lower heart chamber assist device | 23 | $4,189 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,235 | $104 |
| Return visit (30+ min) | 36 | $2,733 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,395 | $160 |
| Hospital discharge day management, more than 30 minutes | 22 | $1,936 | $84 |
| Long return visit (40+ min) | 19 | $1,870 | $81 |
| Long return visit (40+ min) | 15 | $1,704 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $1,400 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $1,050 | $58 |
| Short return visit (20+ min) | 14 | $806 | $40 |
| Short return visit (20+ min) | 13 | $604 | $40 |
| Ultrasound of heart, follow-up | 14 | $266 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $65 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $30 | $3 |
2018: 18 services
| Critical care, first 30-74 minutes | 41 | $30,029 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $17,090 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,491 | $155 |
| Return visit (30+ min) | 51 | $6,124 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $3,635 | $55 |
| Return visit (30+ min) | 44 | $3,616 | $48 |
| Evaluation of lower heart chamber assist device | 18 | $3,581 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,884 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,616 | $56 |
| Hospital discharge day management, more than 30 minutes | 29 | $2,510 | $84 |
| Long return visit (40+ min) | 18 | $1,991 | $80 |
| Short return visit (20+ min) | 29 | $1,280 | $36 |
| Long return visit (40+ min) | 11 | $1,212 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $1,148 | $46 |
| Short return visit (20+ min) | 17 | $720 | $34 |
| Ultrasound of heart, follow-up | 28 | $601 | $21 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 23 | $144 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $89 | $3 |
2017: 18 services
| Critical care, first 30-74 minutes | 47 | $27,747 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $26,451 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,255 | $153 |
| Return visit (30+ min) | 59 | $6,183 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 109 | $5,335 | $49 |
| Return visit (30+ min) | 63 | $5,188 | $51 |
| Hospital discharge day management, more than 30 minutes | 29 | $2,741 | $83 |
| Long return visit (40+ min) | 28 | $2,552 | $82 |
| Long return visit (40+ min) | 18 | $1,516 | $76 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $858 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $849 | $42 |
| Evaluation of lower heart chamber assist device | 14 | $729 | $36 |
| Short return visit (20+ min) | 19 | $673 | $34 |
| Short return visit (20+ min) | 18 | $615 | $34 |
| Ultrasound of heart, follow-up | 29 | $544 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $143 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 24 | $127 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $82 | $2 |
2016: 15 services
| Critical care, first 30-74 minutes | 40 | $31,869 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $31,835 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $8,226 | $147 |
| Return visit (30+ min) | 62 | $6,055 | $57 |
| Return visit (30+ min) | 56 | $5,906 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | $4,899 | $47 |
| Long return visit (40+ min) | 35 | $4,386 | $78 |
| Hospital discharge day management, more than 30 minutes | 43 | $4,006 | $79 |
| New patient visit (60+ min) | 11 | $1,309 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $1,138 | $44 |
| Evaluation of lower heart chamber assist device | 12 | $1,127 | $35 |
| Ultrasound of heart, follow-up | 37 | $829 | $20 |
| Short return visit (20+ min) | 13 | $474 | $32 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 31 | $194 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $110 | $2 |
2015: 13 services
| Critical care, first 30-74 minutes | 40 | $33,777 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $26,376 | $78 |
| Return visit (30+ min) | 116 | $13,895 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,092 | $153 |
| Long return visit (40+ min) | 54 | $5,440 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $5,187 | $46 |
| Short return visit (20+ min) | 38 | $1,773 | $38 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,234 | $95 |
| Evaluation of lower heart chamber assist device | 11 | $984 | $36 |
| Ultrasound of heart, follow-up | 32 | $663 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $172 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $96 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $93 | $6 |
2014: 12 services
| Critical care, first 30-74 minutes | 37 | $37,887 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $36,233 | $76 |
| Return visit (30+ min) | 133 | $17,019 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,107 | $151 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $5,220 | $46 |
| Long return visit (40+ min) | 42 | $3,492 | $83 |
| Short return visit (20+ min) | 42 | $1,601 | $31 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,026 | $79 |
| Ultrasound of heart, follow-up | 26 | $491 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $180 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $103 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $74 | $3 |
2013: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $19,507 | $78 |
| Return visit (30+ min) | 100 | $10,947 | $58 |
| Critical care, first 30-74 minutes | 11 | $6,251 | $160 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,308 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 69 | $3,303 | $47 |
| Long return visit (40+ min) | 25 | $2,093 | $84 |
| Short return visit (20+ min) | 14 | $517 | $37 |
Medicaid work
$14,564 in 2024
Medicaid paid $14,564 for 253 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 95 | $7,086 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 34 | $3,390 |
| Return visit (30+ min) | 61 | $2,430 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 63 | $1,659 |
| 2024 | 253 | 4 | 18 | $14,564 |
| 2023 | 335 | 3 | 20 | $17,271 |
| 2022 | 118 | 2 | 19 | $3,449 |
| 2021 | 74 | 2 | 15 | $3,214 |
| 2020 | 60 | 1 | 14 | $1,829 |
| 2019 | 744 | 8 | 30 | $23,408 |
| 2018 | 751 | 8 | 28 | $28,980 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 83 | $8,417 |
| Long return visit (40+ min) | 135 | $4,468 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 117 | $4,386 |
2022
| Long return visit (40+ min) | 80 | $2,730 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 38 | $719 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 58 | $2,813 |
| Long return visit (40+ min) | 16 | $400 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 60 | $1,829 |
2019
| Return visit (30+ min) | 286 | $12,360 |
| Long return visit (40+ min) | 73 | $3,420 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 57 | $2,095 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 69 | $1,762 |
| Hospital outpatient clinic visit for assessment and management of a patient | 100 | $1,461 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 71 | $1,113 |
| Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum status, recovery), with programming, if performed, and report | 75 | $878 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $320 |
2018
| Return visit (30+ min) | 325 | $17,085 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 209 | $5,897 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 90 | $3,109 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 47 | $2,055 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $460 |
| Short return visit (20+ min) | 16 | $207 |
| Hospital outpatient clinic visit for assessment and management of a patient | 26 | $109 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 19 | $57 |
Drugs they prescribed that Part D paid
$2,226,067
Pharmacies billed $2,226,067 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,964) in 2024. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 0%.
2,792 generic and 1,172 brand-name prescriptions · $2,226,067 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 26 | $657,908 | $25,304 |
| Entresto | 424 | $488,695 | $1,153 |
| Eliquis | 206 | $278,908 | $1,354 |
| Farxiga | 230 | $260,360 | $1,132 |
| Camzyos | 27 | $217,528 | $8,057 |
See all 43 drugs
| Vyndamax | 26 | $657,908 | $25,304 |
| Entresto | 424 | $488,695 | $1,153 |
| Eliquis | 206 | $278,908 | $1,354 |
| Farxiga | 230 | $260,360 | $1,132 |
| Camzyos | 27 | $217,528 | $8,057 |
| Jardiance | 136 | $152,785 | $1,123 |
| Ambrisentan | 11 | $25,323 | $2,302 |
| Xarelto | 16 | $21,163 | $1,323 |
| Repatha Sureclick | 29 | $15,755 | $543 |
| Dapagliflozin | 16 | $10,083 | $630 |
| Torsemide | 154 | $5,700 | $37 |
| Metoprolol | 327 | $5,016 | $15 |
| Carvedilol | 329 | $3,983 | $12 |
| Atorvastatin | 233 | $3,257 | $14 |
| Diltiazem 24hr Er (Cd) | 50 | $2,709 | $54 |
| Ezetimibe | 34 | $2,375 | $70 |
| Rosuvastatin | 77 | $2,112 | $27 |
| Eplerenone | 39 | $2,023 | $52 |
| Losartan | 144 | $1,987 | $14 |
| Spironolactone | 273 | $1,894 | $7 |
| Midodrine | 14 | $1,783 | $127 |
| Furosemide | 265 | $1,724 | $7 |
| Amiodarone | 47 | $1,426 | $30 |
| Bumetanide | 17 | $1,307 | $77 |
| Isosorbide Mononitrate Er | 68 | $1,242 | $18 |
| Hydralazine | 80 | $1,218 | $15 |
| Bisoprolol | 45 | $909 | $20 |
| Clopidogrel | 71 | $871 | $12 |
| Digoxin | 34 | $855 | $25 |
| Potassium Chloride | 18 | $802 | $45 |
| Lisinopril | 82 | $762 | $9 |
| Irbesartan | 17 | $647 | $38 |
| Pantoprazole | 32 | $587 | $18 |
| Amlodipine Besylate | 81 | $507 | $6 |
| Fenofibrate | 11 | $487 | $44 |
| Telmisartan-Hydrochlorothiazid | 11 | $380 | $35 |
| Isosorbide Dinitrate | 12 | $339 | $28 |
| Famotidine | 31 | $308 | $10 |
| Metolazone | 12 | $265 | $22 |
| Pravastatin | 17 | $209 | $12 |
| Nitroglycerin | 13 | $125 | $10 |
| Metoprolol | 20 | $63 | $3 |
| Hydrochlorothiazide | 14 | $45 | $3 |
Year by year
| 2024 | 3,964 | 443 | 0% (0) | 30% | $2,226,067 |
| 2023 | 3,447 | 399 | 0% (0) | 29% | $1,368,741 |
| 2022 | 2,630 | 286 | 0% (0) | 28% | $917,278 |
| 2021 | 1,797 | 186 | 0% (0) | 23% | $619,854 |
| 2020 | 1,551 | 246 | 0% (0) | None | $145,306 |
| 2019 | 3,329 | 241 | None | None | $250,820 |
| 2018 | 3,287 | 223 | 0% (0) | 13% | $192,050 |
| 2017 | 3,645 | 229 | None | None | $137,743 |
| 2016 | 3,727 | 236 | None | 9% | $108,679 |
| 2015 | 3,945 | 238 | None | 11% | $164,327 |
| 2014 | 3,393 | 224 | None | None | $135,445 |
| 2013 | 2,052 | 193 | None | None | $78,363 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Entresto | 392 | $418,877 | $1,069 |
| Eliquis | 163 | $191,967 | $1,178 |
| Farxiga | 192 | $183,271 | $955 |
| Jardiance | 149 | $158,645 | $1,065 |
| Camzyos | 13 | $107,677 | $8,283 |
| Xarelto | 17 | $16,150 | $950 |
| Torsemide | 170 | $7,297 | $43 |
| Metoprolol | 287 | $6,233 | $22 |
| Carvedilol | 314 | $5,776 | $18 |
| Losartan | 130 | $3,467 | $27 |
| Atorvastatin | 214 | $3,424 | $16 |
| Diltiazem 24hr Er (Cd) | 41 | $3,303 | $81 |
| Isosorbide Mononitrate Er | 83 | $2,368 | $29 |
| Spironolactone | 215 | $2,252 | $10 |
| Eplerenone | 23 | $2,060 | $90 |
| Digoxin | 22 | $1,933 | $88 |
| Furosemide | 244 | $1,834 | $8 |
| Rosuvastatin | 57 | $1,708 | $30 |
| Hydralazine | 64 | $1,544 | $24 |
| Midodrine | 16 | $1,341 | $84 |
| Clopidogrel | 59 | $1,285 | $22 |
| Lisinopril | 93 | $1,135 | $12 |
| Amiodarone | 26 | $1,116 | $43 |
| Irbesartan | 17 | $1,047 | $62 |
| Potassium Chloride | 26 | $901 | $35 |
| Ezetimibe | 20 | $741 | $37 |
| Bisoprolol | 19 | $687 | $36 |
| Pravastatin | 21 | $417 | $20 |
| Amlodipine Besylate | 73 | $380 | $5 |
| Famotidine | 23 | $348 | $15 |
| Isosorbide Dinitrate | 13 | $295 | $23 |
| Nitroglycerin | 21 | $269 | $13 |
| Metoprolol | 21 | $194 | $9 |
| Pantoprazole | 17 | $156 | $9 |
| Omeprazole | 11 | $121 | $11 |
| Amoxicillin | 11 | $14 | $1 |
2022: 28 drugs
| Entresto | 307 | $292,329 | $952 |
| Eliquis | 117 | $108,148 | $924 |
| Farxiga | 130 | $105,698 | $813 |
| Jardiance | 65 | $55,824 | $859 |
| Torsemide | 160 | $6,054 | $38 |
| Metoprolol | 192 | $4,822 | $25 |
| Carvedilol | 257 | $3,835 | $15 |
| Eplerenone | 23 | $2,113 | $92 |
| Atorvastatin | 144 | $2,094 | $15 |
| Hydralazine | 88 | $1,963 | $22 |
| Spironolactone | 153 | $1,758 | $11 |
| Isosorbide Dinitrate | 16 | $1,561 | $98 |
| Isosorbide Mononitrate Er | 61 | $1,538 | $25 |
| Furosemide | 175 | $1,414 | $8 |
| Losartan | 93 | $1,269 | $14 |
| Amiodarone | 24 | $1,116 | $47 |
| Lisinopril | 90 | $1,022 | $11 |
| Rosuvastatin | 34 | $784 | $23 |
| Clopidogrel | 36 | $784 | $22 |
| Potassium Chloride | 25 | $666 | $27 |
| Diltiazem 24hr Er (Cd) | 20 | $652 | $33 |
| Amlodipine Besylate | 57 | $497 | $9 |
| Famotidine | 28 | $489 | $17 |
| Pantoprazole | 32 | $413 | $13 |
| Isosorbide Mononitrate | 13 | $345 | $27 |
| Nitroglycerin | 11 | $284 | $26 |
| Bisoprolol | 17 | $268 | $16 |
| Metoprolol | 18 | $232 | $13 |
2021: 27 drugs
| Vyndamax | 16 | $325,023 | $20,314 |
| Entresto | 125 | $110,778 | $886 |
| Eliquis | 86 | $71,530 | $832 |
| Farxiga | 76 | $59,432 | $782 |
| Jardiance | 14 | $7,679 | $548 |
| Metoprolol | 125 | $4,008 | $32 |
| Torsemide | 91 | $2,377 | $26 |
| Tadalafil | 11 | $2,324 | $211 |
| Atorvastatin | 118 | $2,033 | $17 |
| Carvedilol | 127 | $1,923 | $15 |
| Diltiazem 24hr Er (Cd) | 19 | $1,673 | $88 |
| Spironolactone | 118 | $1,472 | $12 |
| Isosorbide Mononitrate Er | 54 | $1,126 | $21 |
| Hydralazine | 60 | $1,124 | $19 |
| Losartan | 75 | $1,091 | $15 |
| Furosemide | 139 | $986 | $7 |
| Rosuvastatin | 47 | $974 | $21 |
| Irbesartan | 12 | $931 | $78 |
| Lisinopril | 63 | $587 | $9 |
| Amlodipine Besylate | 79 | $575 | $7 |
| Pantoprazole | 34 | $572 | $17 |
| Propranolol Hcl Er | 17 | $552 | $32 |
| Potassium Chloride | 19 | $276 | $15 |
| Nitroglycerin | 16 | $274 | $17 |
| Famotidine | 13 | $228 | $18 |
| Clopidogrel | 23 | $186 | $8 |
| Metoprolol | 18 | $144 | $8 |
2020: 21 drugs
| Entresto | 87 | $63,828 | $734 |
| Eliquis | 33 | $19,272 | $584 |
| Metoprolol | 166 | $4,023 | $24 |
| Torsemide | 86 | $2,259 | $26 |
| Carvedilol | 125 | $1,495 | $12 |
| Spironolactone | 124 | $1,329 | $11 |
| Atorvastatin | 105 | $1,294 | $12 |
| Rosuvastatin | 33 | $1,071 | $32 |
| Hydralazine | 54 | $1,049 | $19 |
| Isosorbide Mononitrate Er | 54 | $893 | $17 |
| Digoxin | 30 | $776 | $26 |
| Losartan | 53 | $651 | $12 |
| Furosemide | 119 | $575 | $5 |
| Pantoprazole | 35 | $551 | $16 |
| Lisinopril | 68 | $550 | $8 |
| Potassium Chloride | 11 | $498 | $45 |
| Warfarin | 14 | $337 | $24 |
| Amlodipine Besylate | 41 | $165 | $4 |
| Omeprazole | 22 | $164 | $7 |
| Metoprolol | 33 | $137 | $4 |
| Allopurinol | 12 | $135 | $11 |
2019: 36 drugs
| Entresto | 143 | $100,619 | $704 |
| Eliquis | 75 | $48,995 | $653 |
| Metoprolol | 273 | $8,596 | $31 |
| Torsemide | 168 | $5,735 | $34 |
| Digoxin | 134 | $4,252 | $32 |
| Hydralazine | 187 | $3,737 | $20 |
| Isosorbide Mononitrate Er | 175 | $3,138 | $18 |
| Carvedilol | 258 | $2,979 | $12 |
| Spironolactone | 252 | $2,866 | $11 |
| Atorvastatin | 168 | $2,858 | $17 |
| Isosorbide Dinitrate | 28 | $2,150 | $77 |
| Cyclosporine Modified | 13 | $1,717 | $132 |
| Nifedipine Er | 40 | $1,662 | $42 |
| Warfarin | 88 | $1,649 | $19 |
| Candesartan Cilexetil | 20 | $1,567 | $78 |
| Toprol Xl | 24 | $1,509 | $63 |
| Furosemide | 267 | $1,409 | $5 |
| Potassium Chloride | 36 | $1,306 | $36 |
| Lisinopril | 154 | $908 | $6 |
| Rosuvastatin | 30 | $863 | $29 |
| Losartan | 70 | $838 | $12 |
| Digox | 31 | $747 | $24 |
| Amlodipine Besylate | 92 | $614 | $7 |
| Pantoprazole | 57 | $613 | $11 |
| Pravastatin | 25 | $575 | $23 |
| Simvastatin | 39 | $556 | $14 |
| Metoprolol | 78 | $531 | $7 |
| Omeprazole | 36 | $394 | $11 |
| Clopidogrel | 29 | $378 | $13 |
| Jantoven | 21 | $330 | $16 |
| Amiodarone | 14 | $314 | $22 |
| Famotidine | 19 | $314 | $17 |
| Ramipril | 11 | $215 | $20 |
| Allopurinol | 11 | $186 | $17 |
| Prednisone | 16 | $73 | $5 |
| Hydrochlorothiazide | 17 | $23 | $1 |
2018: 39 drugs
| Entresto | 110 | $72,884 | $663 |
| Eliquis | 34 | $19,527 | $574 |
| Metoprolol | 256 | $11,142 | $44 |
| Corlanor | 22 | $6,245 | $284 |
| Torsemide | 188 | $4,918 | $26 |
| Digoxin | 113 | $4,195 | $37 |
| Isosorbide Mononitrate Er | 178 | $4,063 | $23 |
| Hydralazine | 223 | $3,391 | $15 |
| Atorvastatin | 165 | $2,738 | $17 |
| Spironolactone | 241 | $2,369 | $10 |
| Carvedilol | 248 | $2,082 | $8 |
| Eplerenone | 14 | $1,912 | $137 |
| Digox | 57 | $1,554 | $27 |
| Isosorbide Dinitrate | 25 | $1,505 | $60 |
| Warfarin | 88 | $1,471 | $17 |
| Furosemide | 291 | $1,433 | $5 |
| Cyclosporine Modified | 11 | $1,366 | $124 |
| Rosuvastatin | 36 | $1,354 | $38 |
| Losartan | 71 | $1,039 | $15 |
| Toprol Xl | 20 | $1,024 | $51 |
| Lisinopril | 169 | $974 | $6 |
| Potassium Chloride | 17 | $810 | $48 |
| Pravastatin | 41 | $766 | $19 |
| Candesartan Cilexetil | 12 | $661 | $55 |
| Clopidogrel | 34 | $553 | $16 |
| Pantoprazole | 52 | $473 | $9 |
| Omeprazole | 36 | $445 | $12 |
| Amlodipine Besylate | 75 | $436 | $6 |
| Simvastatin | 54 | $435 | $8 |
| Nifedipine Er | 25 | $410 | $16 |
| Amiodarone | 25 | $371 | $15 |
| Famotidine | 26 | $318 | $12 |
| Nitroglycerin | 13 | $282 | $22 |
| Allopurinol | 19 | $276 | $15 |
| Jantoven | 22 | $274 | $12 |
| Metoprolol | 39 | $272 | $7 |
| Prednisone | 28 | $174 | $6 |
| Ramipril | 15 | $133 | $9 |
| Alendronate | 12 | $86 | $7 |
2017: 49 drugs
| Entresto | 37 | $19,201 | $519 |
| Eliquis | 31 | $12,955 | $418 |
| Metoprolol | 255 | $9,808 | $38 |
| Corlanor | 33 | $8,897 | $270 |
| Xarelto | 15 | $5,781 | $385 |
| Digoxin | 134 | $5,140 | $38 |
| Isosorbide Mononitrate Er | 220 | $4,240 | $19 |
| Hydralazine | 254 | $4,043 | $16 |
| Torsemide | 164 | $3,669 | $22 |
| Potassium Chloride | 59 | $3,222 | $55 |
| Milrinone Lactate | 51 | $3,189 | $63 |
| Atorvastatin | 174 | $2,389 | $14 |
| Warfarin | 146 | $2,172 | $15 |
| Carvedilol | 283 | $2,002 | $7 |
| Eplerenone | 16 | $1,714 | $107 |
| Spironolactone | 236 | $1,621 | $7 |
| Cyclosporine Modified | 11 | $1,367 | $124 |
| Toprol Xl | 23 | $1,363 | $59 |
| Lisinopril | 219 | $1,303 | $6 |
| Rosuvastatin | 31 | $1,212 | $39 |
| Losartan | 93 | $1,186 | $13 |
| Furosemide | 283 | $1,181 | $4 |
| Digox | 26 | $1,118 | $43 |
| Nifedipine Er | 36 | $1,058 | $29 |
| Mexiletine | 13 | $1,058 | $81 |
| Candesartan Cilexetil | 13 | $802 | $62 |
| Valsartan | 16 | $757 | $47 |
| Clopidogrel | 32 | $586 | $18 |
| Omeprazole | 39 | $546 | $14 |
| Amlodipine Besylate | 91 | $523 | $6 |
| Pravastatin | 36 | $499 | $14 |
| Fenofibrate | 14 | $452 | $32 |
| Diltiazem 24hr Er | 13 | $448 | $34 |
| Amiodarone | 37 | $377 | $10 |
| Allopurinol | 12 | $324 | $27 |
| Digitek | 14 | $316 | $23 |
| Metolazone | 15 | $315 | $21 |
| Sotalol | 11 | $286 | $26 |
| Nitroglycerin | 12 | $244 | $20 |
| Simvastatin | 66 | $235 | $4 |
| Pantoprazole | 25 | $232 | $9 |
| Ramipril | 21 | $203 | $10 |
| Prednisone | 19 | $182 | $10 |
| Jantoven | 31 | $133 | $4 |
| Metoprolol | 21 | $128 | $6 |
| Hydrochlorothiazide | 23 | $118 | $5 |
| Famotidine | 17 | $62 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $54 | $5 |
| Meclizine | 12 | $36 | $3 |
2016: 45 drugs
| Metoprolol | 300 | $8,654 | $29 |
| Milrinone Lactate | 52 | $7,604 | $146 |
| Torsemide | 169 | $5,820 | $34 |
| Hydralazine | 241 | $4,679 | $19 |
| Corlanor | 21 | $4,588 | $218 |
| Digoxin | 158 | $4,241 | $27 |
| Isosorbide Mononitrate Er | 238 | $3,763 | $16 |
| Potassium Chloride | 84 | $2,714 | $32 |
| Colchicine | 11 | $2,499 | $227 |
| Gengraf | 17 | $2,373 | $140 |
| Warfarin | 157 | $2,109 | $13 |
| Carvedilol | 300 | $1,973 | $7 |
| Tacrolimus | 14 | $1,937 | $138 |
| Atorvastatin | 128 | $1,811 | $14 |
| Isosorbide Dinitrate | 18 | $1,611 | $90 |
| Lisinopril | 301 | $1,594 | $5 |
| Spironolactone | 251 | $1,496 | $6 |
| Bumetanide | 15 | $1,421 | $95 |
| Digox | 31 | $1,220 | $39 |
| Toprol Xl | 17 | $992 | $58 |
| Candesartan Cilexetil | 12 | $950 | $79 |
| Amiodarone | 47 | $839 | $18 |
| Pravastatin | 48 | $802 | $17 |
| Furosemide | 187 | $743 | $4 |
| Valsartan | 22 | $611 | $28 |
| Losartan | 89 | $596 | $7 |
| Taztia Xt | 11 | $555 | $50 |
| Omeprazole | 50 | $550 | $11 |
| Klor-Con M20 | 14 | $550 | $39 |
| Ramipril | 30 | $456 | $15 |
| Allopurinol | 26 | $417 | $16 |
| Metolazone | 29 | $352 | $12 |
| Simvastatin | 78 | $341 | $4 |
| Fenofibrate | 12 | $323 | $27 |
| Clopidogrel | 25 | $308 | $12 |
| Amlodipine Besylate | 79 | $304 | $4 |
| Digitek | 18 | $293 | $16 |
| Nitrostat | 12 | $289 | $24 |
| Sildenafil | 23 | $282 | $12 |
| Jantoven | 41 | $205 | $5 |
| Hydrochlorothiazide | 27 | $154 | $6 |
| Meclizine | 15 | $129 | $9 |
| Prednisone | 18 | $110 | $6 |
| Metoprolol | 29 | $109 | $4 |
| Bisoprolol-Hydrochlorothiazide | 16 | $89 | $6 |
2015: 55 drugs
| Milrinone Lactate | 38 | $11,609 | $306 |
| Metoprolol | 275 | $10,176 | $37 |
| Tacrolimus | 26 | $7,552 | $290 |
| Torsemide | 209 | $6,558 | $31 |
| Hydralazine | 235 | $5,417 | $23 |
| Brilinta | 14 | $5,341 | $381 |
| Xarelto | 11 | $5,144 | $468 |
| Digoxin | 151 | $4,772 | $32 |
| Sildenafil | 19 | $4,743 | $250 |
| Eplerenone | 34 | $3,786 | $111 |
| Valsartan | 33 | $3,577 | $108 |
| Isosorbide Mononitrate Er | 220 | $3,523 | $16 |
| Bumetanide | 27 | $3,273 | $121 |
| Warfarin | 185 | $3,048 | $16 |
| Nexium | 12 | $2,979 | $248 |
| Isosorbide Dinitrate | 28 | $2,818 | $101 |
| Carvedilol | 280 | $2,351 | $8 |
| Mycophenolate Mofetil | 21 | $2,056 | $98 |
| Potassium Chloride | 72 | $1,917 | $27 |
| Atorvastatin | 97 | $1,834 | $19 |
| Fenofibrate | 19 | $1,751 | $92 |
| Toprol Xl | 24 | $1,698 | $71 |
| Spironolactone | 219 | $1,568 | $7 |
| Gengraf | 13 | $1,554 | $120 |
| Lisinopril | 298 | $1,440 | $5 |
| Digox | 39 | $1,398 | $36 |
| Pravastatin | 47 | $1,270 | $27 |
| Cartia Xt | 21 | $1,092 | $52 |
| Amiodarone | 28 | $1,065 | $38 |
| Losartan | 112 | $948 | $8 |
| Diltiazem 24hr Er | 19 | $876 | $46 |
| Candesartan Cilexetil | 11 | $820 | $75 |
| Furosemide | 193 | $798 | $4 |
| Digitek | 30 | $783 | $26 |
| Klor-Con M20 | 18 | $716 | $40 |
| Ramipril | 38 | $609 | $16 |
| Clopidogrel | 48 | $573 | $12 |
| Allopurinol | 34 | $523 | $15 |
| Amlodipine Besylate | 83 | $509 | $6 |
| Metolazone | 18 | $494 | $27 |
| Enalapril Maleate | 18 | $419 | $23 |
| Omeprazole | 45 | $417 | $9 |
| Alendronate | 16 | $377 | $24 |
| Pantoprazole | 31 | $373 | $12 |
| Simvastatin | 85 | $335 | $4 |
| Tamsulosin | 11 | $309 | $28 |
| Levothyroxine | 15 | $277 | $18 |
| Hydrochlorothiazide | 39 | $241 | $6 |
| Jantoven | 33 | $234 | $7 |
| Prednisone | 25 | $211 | $8 |
| Bisoprolol-Hydrochlorothiazide | 32 | $180 | $6 |
| Diltiazem | 11 | $157 | $14 |
| Meclizine | 11 | $109 | $10 |
| Metoprolol | 19 | $79 | $4 |
| Ranitidine | 14 | $54 | $4 |
2014: 48 drugs
| Metoprolol | 269 | $12,972 | $48 |
| Nexium | 20 | $7,091 | $355 |
| Hydralazine | 189 | $5,268 | $28 |
| Brilinta | 14 | $5,049 | $361 |
| Tacrolimus | 20 | $4,851 | $243 |
| Diovan | 16 | $4,269 | $267 |
| Torsemide | 131 | $4,103 | $31 |
| Digoxin | 108 | $3,937 | $36 |
| Isosorbide Mononitrate Er | 156 | $2,850 | $18 |
| Carvedilol | 242 | $2,546 | $11 |
| Atorvastatin | 107 | $2,525 | $24 |
| Isosorbide Dinitrate | 16 | $2,484 | $155 |
| Colcrys | 14 | $2,211 | $158 |
| Mycophenolate Mofetil | 13 | $1,931 | $149 |
| Digox | 58 | $1,844 | $32 |
| Potassium Chloride | 51 | $1,727 | $34 |
| Lisinopril | 257 | $1,606 | $6 |
| Spironolactone | 186 | $1,570 | $8 |
| Eplerenone | 12 | $1,544 | $129 |
| Bumetanide | 33 | $1,524 | $46 |
| Klor-Con M20 | 63 | $1,411 | $22 |
| Warfarin | 122 | $1,389 | $11 |
| Pravastatin | 42 | $1,258 | $30 |
| Losartan | 96 | $1,215 | $13 |
| Toprol Xl | 22 | $1,068 | $49 |
| Pantoprazole | 71 | $905 | $13 |
| Furosemide | 179 | $888 | $5 |
| Diltiazem 24hr Er | 25 | $879 | $35 |
| Coumadin | 12 | $877 | $73 |
| Ramipril | 23 | $783 | $34 |
| Simvastatin | 90 | $561 | $6 |
| Omeprazole | 48 | $514 | $11 |
| Amlodipine Besylate | 52 | $412 | $8 |
| Metolazone | 32 | $380 | $12 |
| Allopurinol | 43 | $371 | $9 |
| Alendronate | 19 | $365 | $19 |
| Bupropion Xl | 11 | $364 | $33 |
| Diltiazem 24hr Cd | 11 | $331 | $30 |
| Hydrochlorothiazide | 57 | $299 | $5 |
| Bisoprolol-Hydrochlorothiazide | 35 | $266 | $8 |
| Gabapentin | 12 | $243 | $20 |
| Prednisone | 28 | $220 | $8 |
| Meclizine | 20 | $211 | $11 |
| Enalapril Maleate | 21 | $186 | $9 |
| Clopidogrel | 14 | $140 | $10 |
| Diltiazem | 12 | $136 | $11 |
| Jantoven | 22 | $101 | $5 |
| Clonidine | 11 | $28 | $3 |
2013: 38 drugs
| Metoprolol | 170 | $7,391 | $43 |
| Nexium | 12 | $5,763 | $480 |
| Torsemide | 89 | $3,626 | $41 |
| Eplerenone | 21 | $3,367 | $160 |
| Hydralazine | 134 | $3,325 | $25 |
| Mycophenolate Mofetil | 18 | $2,661 | $148 |
| Diovan | 12 | $2,455 | $205 |
| Isosorbide Mononitrate Er | 120 | $1,942 | $16 |
| Isosorbide Dinitrate | 19 | $1,726 | $91 |
| Carvedilol | 137 | $1,603 | $12 |
| Lisinopril | 206 | $1,528 | $7 |
| Spironolactone | 127 | $1,230 | $10 |
| Atorvastatin | 49 | $1,182 | $24 |
| Potassium Chloride | 27 | $1,038 | $38 |
| Losartan | 59 | $1,025 | $17 |
| Pravastatin | 20 | $677 | $34 |
| Klor-Con M20 | 32 | $665 | $21 |
| Warfarin | 47 | $640 | $14 |
| Simvastatin | 70 | $627 | $9 |
| Furosemide | 100 | $574 | $6 |
| Digox | 51 | $569 | $11 |
| Diltiazem 24hr Er | 19 | $505 | $27 |
| Diltiazem Er | 11 | $417 | $38 |
| Diltiazem 24hr Cd | 14 | $378 | $27 |
| Clopidogrel | 11 | $372 | $34 |
| Amiodarone | 16 | $362 | $23 |
| Bumetanide | 20 | $340 | $17 |
| Omeprazole | 23 | $287 | $12 |
| Amlodipine Besylate | 37 | $259 | $7 |
| Allopurinol | 37 | $255 | $7 |
| Bisoprolol-Hydrochlorothiazide | 24 | $208 | $9 |
| Pantoprazole | 14 | $187 | $13 |
| Metolazone | 14 | $171 | $12 |
| Meclizine | 12 | $130 | $11 |
| Hydrochlorothiazide | 18 | $102 | $6 |
| Digoxin | 20 | $100 | $5 |
| Jantoven | 16 | $71 | $4 |
| Prednisone | 11 | $71 | $6 |
Money from drug and device companies
$37 in 2025
| 2025 | 1 | 2 | None | $37 |
| 2024 | 3 | 3 | None | $281 |
| 2023 | 4 | 4 | $1,611 | $1,699 |
| 2022 | 3 | 10 | None | $774 |
| 2021 | 2 | 5 | $1,074 | $1,276 |
| 2020 | 1 | 1 | None | $16 |
| 2019 | 12 | 40 | $3,750 | $5,534 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Camzyos | $37 | 2 payments
|
See all 2 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-08 | Eliquis | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-01 | Camzyos | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $281
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
| Novo Nordisk | None | $122 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $30 | 1 payment
|
2023: $1,699
| AstraZeneca Pharmaceuticals LP | None | $1,611 | 1 payment
|
| Daiichi Sankyo | Injectafer | $43 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $27 | 1 payment
|
| Scpharmaceuticals | Furoscix | $18 | 1 payment
|
2022: $774
| Abbott Laboratories | Cardiomems | $677 | 8 payments
|
| Novartis Pharmaceuticals | Entresto | $70 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $27 | 1 payment
|
2021: $1,276
| AstraZeneca Pharmaceuticals LP | None | $1,074 | 1 payment
|
| Abbott Laboratories | Cardiomems Hf System | $202 | 4 payments
|
2020: $16
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
2019: $5,534
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $4,417 | 12 payments
|
| Abbott Laboratories | Cardiomems Hf System | $718 | 8 payments
|
| Pfizer | Vyndaqel | $155 | 6 payments
|
| Amgen | Corlanor | $95 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $31 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $14 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $14 | 1 payment
|
| Amarin Pharma | Vascepa | $12 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $11 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Amgen Inc. · Galactic-Hf · 2019 | Their institution | $95,696 |
| Amgen Inc. · Galactic - Hf · 2020 | Their institution | $32,994 |
Professional record
- NPI
- 1518052877
- Licence
- CA A114478, OH 35-090935, WI 49687-020California A114478: Current · expires 2027-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- OH 0066171
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-10-04
- NPI last updated
- 2020-11-03
- NPI record certified
- 2020-11-03
This is when the NPI record was last certified, not a medical board exam.